Growth factors and carcinoid tumours
- PMID: 8323752
- DOI: 10.3109/02841869309083899
Growth factors and carcinoid tumours
Abstract
The presence of growth factors and their receptors in human midgut carcinoids and in gastric carcinoids of Mastomys have been investigated. Human midgut carcinoid tumours produce IGF-I as demonstrated by immunocytochemistry and radioimmunoassay. IGF-I receptors were detectable in half of the tumours and stimulation of cultured tumour cells with IGF-I enhanced DNA synthesis. IGF-I may therefore act as an autocrine stimulator of carcinoid tumour growth. Expression of TGF-alpha and EGF-receptors could also be demonstrated in midgut carcinoids by immunocytochemistry and Northern analysis, suggesting that TGF-alpha participates in the autocrine modulation of carcinoid growth. Co-culture of human midgut carcinoid tumours and rat fetal cholinergic neurons demonstrated secretion of a potent neuronotrophic factor by cultured tumour cells. IGF-I and TGF-alpha may account for these neuronotrophic effects, but carcinoid tumours may also secrete an as yet unidentified growth factor. Gastric (ECL cell) carcinoids developed rapidly in Mastomys during hypergastrinemia due to histamine2-receptor blockade, suggesting that gastrin is an essential growth factor for these carcinoids.
Similar articles
-
Presence of IGF-I in human midgut carcinoid tumours--an autocrine regulator of carcinoid tumour growth?Int J Cancer. 1992 May 8;51(2):195-203. doi: 10.1002/ijc.2910510206. Int J Cancer. 1992. PMID: 1314781
-
The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent mastomys.Gastroenterology. 1996 Nov;111(5):1212-23. doi: 10.1053/gast.1996.v111.pm8898635. Gastroenterology. 1996. PMID: 8898635
-
Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation.Regul Pept. 1999 Dec 23;85(2-3):115-23. doi: 10.1016/s0167-0115(99)00086-5. Regul Pept. 1999. PMID: 10651065
-
Praomys (Mastomys) natalensis: a model for gastric carcinoid formation.Yale J Biol Med. 1992 Nov-Dec;65(6):741-51; discussion 827-9. Yale J Biol Med. 1992. PMID: 1341076 Free PMC article. Review.
-
Histamine metabolism of gastric carcinoids in Mastomys natalensis.Yale J Biol Med. 1998 May-Aug;71(3-4):207-15. Yale J Biol Med. 1998. PMID: 10461353 Free PMC article. Review.
Cited by
-
A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839).Br J Cancer. 2003 Nov 3;89(9):1766-75. doi: 10.1038/sj.bjc.6601346. Br J Cancer. 2003. PMID: 14583782 Free PMC article.
-
What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?Curr Oncol Rep. 2022 Oct;24(10):1281-1286. doi: 10.1007/s11912-022-01211-5. Epub 2022 May 13. Curr Oncol Rep. 2022. PMID: 35554845 Free PMC article. Review.
-
Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.World J Gastroenterol. 2008 Apr 28;14(16):2461-73. doi: 10.3748/wjg.14.2461. World J Gastroenterol. 2008. PMID: 18442192 Free PMC article. Review.
-
Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis.Int J Colorectal Dis. 2006 Apr;21(3):221-30. doi: 10.1007/s00384-005-0779-5. Epub 2005 Jun 14. Int J Colorectal Dis. 2006. PMID: 16485142
-
Pathogenesis and Clinical Management of Mesenteric Fibrosis in Small Intestinal Neuroendocine Neoplasms: A Systematic Review.J Clin Med. 2020 Jun 8;9(6):1777. doi: 10.3390/jcm9061777. J Clin Med. 2020. PMID: 32521677 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical